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ABSTRACT 
The World Health Organization (WHO) estimates that waterborne diseases alone 
account for over 3.4 million deaths per year. With such a high mortality, the need to 
provide a fast and accurate means of identifying the cause of the microbial infection is 
fundamental to the quality of care and paramount to public health. In resource-poor 
settings a shortage of clinics pose a major problem, as patients are required to travel long 
distances, many of which cannot afford the return trip to retrieve their test results. 
Between visits most clinics are limited to microscopic analyses, telehistology, or media-
based metabolic tests, which can take as long as a week. In addition, less-monitored 
water supplies in these areas become breeding grounds for bacteria that can affect an 
entire community. Overall the developing world lacks the advanced pathogen detection 
and water treatment technology of first world countries. Due to the costs and training 
associated with such technology, it is not feasible for the developing world to house these 
advancements. Recently there has been a push to provide affordable devices for these 
countries. Although diagnostics have made improvements in recent years, there is still a 
need for quick and more affordable tests to identify microbial infectious agents.   
The basis of the proposed technology allows the individual to identify the 
presence of a waterborne pathogen within 10-15 minutes, much less than the traditional 
time-consuming cell culture technique. Scientific literature confirms that lectins, 
specifically sugar-binding plant proteins, have been observed to agglutinate with a variety 
of pathogens. With this binding as a foundation, the group has successfully designed 
impedimetric biosensors that respond via a change in resistance when foreign pathogens 
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are introduced. Proof of concept testing has confirmed the technology's ability to detect 
for the presence of pathogens at clinically relevant concentrations.  
In the future this impedimetric technology can be used for the development of two 
novel devices: 1. a low-cost point-of-care clinical diagnostic for measuring and 
identifying the presence of pathogenic agents and 2. a low-cost in-line system for 
automated remote testing of biological contamination in water systems.  
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CHAPTER ONE 
 
IMPEDIMETRIC BIOSENSORS FOR PATHOGEN DETECTION IN LOW-
RESOURCE SETTINGS 
 
This chapter serves to set the framework for the technology's commercial 
potential as well as to summarize the underlying principles of the technology. This 
chapter also outlines later chapters covered in this thesis and how they relate to the 
technology discussed. 
 
1.1 Biosensor Market Performance and Projections 
 
Due to the technology's ability to detect and transmit information about a 
biological process it can be classified as a biosensor. This market is particularly 
promising due to the millions of individuals that it could reach globally [1]. Biosensors 
are quickly gaining popularity worldwide due to their numerous applications in medical 
diagnostics, the food industry, biodefense, pharmaceuticals, and industrial processes. Top 
competitors in the biosensor market include Abbot Point of Care, Medtronic, LifeScan, 
and Siemens Healthcare, etc. Currently their most prominent application can be found in 
blood glucose monitors. However, their prevalence has recently been seen in areas such 
as infectious disease monitoring, industrial biology, and food toxicity detection among 
others.  
  The biosensors market as a whole can be broken down into four major categories: 
electrochemical, optical, piezoelectric, and thermal [2]. The total biosensor market was 
valued at $12.96 billion dollars in 2014 and is expected to reach $22.49 billion dollars by 
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2020. This growth is based off of a projected compound annual growth rate (CAGR) of 
9.7%. Of the total biosensor market the United States controls approximately 40%, 
leading the total U.S. biosensor market to have a value of $6.24 billion dollars for 2016. 
Narrowing this down further the point-of-care diagnostics market encompasses 50% of 
the biosensors market. This percentage puts the total 2016 U.S. POC biosensor market at 
$3.12 billion dollars. The largest share of the market is medical testing, projected to 
exhibit strong growth due to the increasing prevalence of diabetes [3]. 
 Recent advancement in the field of electrochemical sensors, the largest category 
of biosensors, has led to an increase in the POC diagnostics market according to 
Kalorama's 2015 World Market for Point of Care (POC) Diagnostics. In 2014 the POC 
testing market reached $17 billion dollars globally and is expected to reach $20.4 billion 
dollars by 2019 with a CAGR of 3.7%. Over the past few years, the increasing integration 
of portable, handheld instruments has allowed for medical testing to be performed at 
home or at the workplace compared to traditional hospital environments [4].  
  Another area of interest, particularly for a low-cost in-line system biosensor, is 
the water treatment market. According to SBI Energy's Water Treatment Technologies 
and Product Markets, 2006-2015, the global water treatment market was valued at $463 
billion dollars in 2012. Two essential categories of this market, water utilities and 
household water, account for 75%, or $349 billion dollars alone [5]. In resource-poor 
areas such as Sub-Saharan Africa water purification methods are limited to solar water 
disinfection, chlorination, biosand filters, and boiling [6]. Although these methods may 
remove some bacteria, they aren't as nearly as effective as the complex systems found in 
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developed countries. The residential water treatment expenditures can be seen in Figure 
1.1 below. In this figure there is a large gap between the developed and the resource-poor 
regions. This difference emphasizes the need for the in-line system to be low-cost, 
thereby being a solution for poverty-stricken regions. 
 
 
 
 
 
 
 
 
 
1.2 Detection of Microbial Agents via Lectin-Specific Binding 
 
The research group has developed a novel way to test for microbial agents using 
copper electrodes coated with lectins, or sugar-binding plant proteins. During testing the 
group found that following the introduction of bacteria, the pathogen binds strongly to the 
lectin-coated electrodes. This binding impedes the flow of electricity passing between the 
two electrodes, thereby increasing the resistance. A schematic showing the working 
principle of the technology can be seen in Figure 1.2. Bacteria, as natural insulators, bind 
to lectins, which can exhibit a higher affinity for specific pathogens. For example, in the 
figure below Escherichia coli (E. coli) demonstrated exceptional binding to Concanavalin 
A (ConA), while roughly maintaining equilibrium resistance for BSA. By quantifying the 
Figure 1.1: Residential Water Treatment Market by Region in billions of dollars [5]. 
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change in resistance and comparing the change to how bacteria interacts with wires 
coated in a non-reactive blood protein, a diagnosis can be achieved as to the presence of a 
significant amount of bacteria. This technology is currently being tested as a solution for 
detecting pathogens in humans or in water sources.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Schematic Showing the Working Principle of the Lectin-based 
Sensors. Example data is also included showing the electrode's response in the 
presence of E. coli. Bacteria bind to the ConA-coated electrode (dark green) but 
only show minimal binding to the control bovine serum albumin (BSA) 
electrode (light green). The orange arrows indicate the addition of bacteria 
followed by an increase in the measured resistance between the ConA electrodes 
within a few minutes.  
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1.3 Overview of Study and Chapters 
 
The aims of these studies were three-fold:  
1. Validate lectins viability for the detection of E. coli  
2.  Design a small, low-cost, modular lectin-based device 
3. Determine how well the device works at distinguishing types of microbial  
     contamination  
The outcomes of these studies serve to prepare the way for low-cost lectin-based 
biosensors and their use in low-resource settings for microbial detection. Chapter 2 
provides an overview of the challenges of waterborne pathogens in the developing world 
including: a discussion of the types of waterborne pathogens, as well as current and 
recommend methods for water treatment. Chapter 3 discusses information on lectin 
binding, the roles of lectins in plants and animals, and related biosensors in literature that 
have the ability to detect for pathogens. The research group's design evolution for the 
lectin-based biosensor can be found in Chapter 4. Chapter 5 describes the basis of the 
technology including clinically relevant and experimental findings. Chapter 6 
summarizes overall conclusions and future work that will need to be done in order for 
devices to be developed for the water treatment and clinical settings. 
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CHAPTER TWO 
THE CHALLENGES OF WATERBORNE PATHOGENS IN THE DEVELOPING 
WORLD  
 
In order to properly examine the need for low-cost microbial sensors in 
developing countries it is essential to examine the challenges waterborne pathogens 
introduce in low-resource settings. The following chapter gives an overview of the 
presence and the effects of waterborne pathogens in the developing world, current 
techniques to detect them, as well as recommended ones in literature to improve the 
water quality in the developing world. 
 
2.1 Overview of Waterborne Pathogens 
 
Waterborne pathogens can be split up into three different classes: bacteria, 
viruses, and parasites. These pathogens are often introduced into water supplies when 
infected individuals deposit fecal matter that contains harmful microbes. In many cases 
this can occur when sewage lacking proper treatment is re-deposited into the water 
system. However, runoff of feces may diffuse into groundwater used as a source of water. 
In order manage the risks of infection it is essential to understand the mechanisms for 
which pathogens can move throughout the environment. A diagram illustrating the 
transmission of waterborne pathogens can be seen in Figure 2.1. Although the movement 
of pathogens creates lower concentrated dilutions, they still pose a risk to society's well 
being [7].  
 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Bacteria 
The first category that makes up waterborne pathogens is bacteria, a large group 
of prokaryotic microorganisms. The size of bacteria can range between a few microns, 
however they can vary significantly between species. Bacteria may be found in the 
shapes of spheres, but also as spirals and rods as well as temperature ranges from subzero 
to boiling [7].  
Bacteria can be split into two different categories: Gram-positive and Gram-
negative. In order to differentiate between the two, scientists perform a Gram-staining 
test. This test involves a staining technique that detects the peptidoglycans of the cell in 
order to gather insight on the bacterium's physical and chemical properties. Once stained, 
Gram-positive bacteria appear purple under a microscope, while Gram-negative bacteria 
remain a pink color. Microscope staining of both Gram-positive and Gram-negative 
Figure 2.1: Transmission Pathways for Waterborne Pathogens [8].  
 
 9 
bacteria can be seen in Figure 2.2. Gram-positive bacteria have a thick, smooth 
peptidoglycan layer that retains most of the stain. Examples of Gram-positive bacteria 
include Staphylococcus aureus, Streptococcus pneumoniae, and Bacillus anthracis 
among others. Gram-negative bacteria, on the contrary, exhibit thin and wavy outer 
membranes.  The National Institute of Allergy and Infectious Diseases currently labels 
Gram-negative bacteria under recent concern due to their increasing resistance to 
antibiotics. Some examples of Gram-negative bacteria include E. coli, the cause of the 
majority of urinary tract infections, as well as Pseudomonas aeruginosa, and Klebsiella 
pneumoniae. The latter two are responsible for healthcare-related drug-resistant 
infections that can enter the body through catheters, wounds, or ventilators and cause 
infections [7]. 
 
 
 
 
 
Figure 2.2:  Microscopic Gram-staining for Gram-positive bacteria (left) and Gram-
negative bacteria (right) [9].   
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 Viruses 
The second category that makes up waterborne pathogens is viruses. Viruses are 
considered the smallest of all three categories, with sizes ranging from 20 to 300 nm. A 
single virus is composed of a layer of protein covering a miniscule amount of nucleic 
acid in the form of RNA or DNA. Once exposed the outermost layer of the virus 
undergoes cell-to-cell interactions via the surface receptors of the organism's cells. These 
infected cells are then guided by the viral nucleic acid to replicate more viruses and 
disperse them systemically [7].  
A large number of the waterborne pathogen viruses are considered gastroenteric 
viruses. These viruses reproduce in the upper parts of the intestine and cause 
inflammation as well as other uncomfortable symptoms such as diarrhea. Although a 
delayed process, the infected intestinal cells are ultimately replaced with those which are 
unaffected by the virus [7].  
 Protozoa 
The third category of waterborne pathogens is protozoa. This group includes a 
various unicellular organisms. Subcategories consist of flagellates (microbes with long, 
tail-like structures), sporozoa (intracellular parasites), ciliates (microbes with an exterior 
with small hair-like structures), and amoeba (organism that moves via temporary 
protrusions called pseudopodia). Cryptosporidium, the most commonly studied member 
of the group, is currently the leading waterborne disease in the United States according to 
the Centers for Disease Control and Prevention (CDC). The microscopic parasite is very 
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resistant to chlorine disinfection due to its outer shell, and causes the diarrheal disease 
cryptosporidiosis [10].  
 
2.2 Effects of Waterborne Pathogens in the Developing World 
 
Albert Szent-Gyorgyi of Hungary, the 1937 Nobel Prize in Medicine winner, once 
stated, "there is no life without water [11]." For developing countries the scarcity of this 
life source is an everyday reality. The World Health Organization (WHO) reports that 
nearly one billion people worldwide lack access to a clean water supply. Of this large 
sum, approximately 2 million deaths occur annually due to an unclean water supply. The 
staggering morbidity rate can be traced back to poor water quality in resource-poor 
settings caused by waterborne pathogens and organic/inorganic chemical compounds. It 
is fundamental to human health for local authorities in resource-poor areas to have the 
tools they need in order to monitor microbial agents and prevent infectious epidemics 
[12].  
Although developing countries still struggle with infectious breakouts due to 
microbial agents in their water supplies, there are specific areas in the world that are more 
affected. In Figure 2.3 Africa, the Middle East, Southeast Asia, and parts of Central and 
South America are linked to a higher number of deaths due to unsafe water, sanitation, 
and hygiene. In these areas a great deal of effort has been put into place in order to reduce 
the amount of pathogen entering the water source. However, the lack of detection 
technologies has left the morbidity rate high. According to Helen Bridle, the author of 
Waterborne Pathogens Detection Methods and Applications, the impact of waterborne 
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pathogens is prevalent in regards to health care costs and lost productivity. For example, 
even with its advanced detection and treatment technology, lost productivity in the 
United States alone costs an estimated $20 million dollars per year due to waterborne 
pathogens [7].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3 Current Water Monitoring Techniques in the Developing World 
Detection techniques play a crucial role in monitoring water quality and providing 
a quantitative microbial risk assessment [14]. Though advanced techniques have detected 
the presence of waterborne pathogens early on in developed countries, those in resource-
poor areas are still exposed to infectious agents. In hopes of preventing outbreaks, 
individuals in the developing world typically rely on two methods for monitoring their 
water supplies. The first method is based on the use of central laboratories to perform 
Figure 2.3: Worldwide Map of the Deaths from Unsafe Water, Sanitation, in Hygiene [13].  
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culture assays and strive to enforce WHO water safety guidelines. These main facilities 
also serve to monitor groundwater contamination as well as to perform studies regarding 
the country's industrial pollution levels and their effects. A second, more bottom-up 
approach utilizes on-site field-testing in order to identify potential infectious agents. In 
this method local communities are trained by organizations such as UNICEF on water 
monitoring techniques such as cell culturing, and are encouraged to come together with 
resources in order to carry these out [15]. Regardless of the approach, there is a heavy 
reliance on a culturing technique that can last weeks [16]. Even if communities can bring 
together the necessary equipment, some of these assays require trained technicians due to 
their vigorous protocols. Traditional techniques also rely off of bioindicators to locate the 
pathogen's presence. The issue with this lies in the lack of correlation between the 
presence of fecal indicators and the pathogens causing the possible health risk. Other 
limitations include bioindicators being limited to bacteria, not currently developed for the 
use of identifying viruses and protozoa. Moreover cell culture techniques are time-
consuming, often requiring training for a bioindicator method that is still limited by 
science. The shortcomings of cell culturing for pathogen detection in the developing 
world further identify the need for an accurate means of identifying infectious pathogens 
in low-resource settings [12].  
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2.4 Recommended Water Monitoring Techniques for the Developing World 
 
Although culture techniques are effective in categorizing the presence of 
microbial agents, they have their limitations. Alhamlan et. al outline advanced detection 
methods for use in the developing world [12]. In this section each of these techniques will 
be summarized along with their respective benefits and drawbacks.  
Molecular detection techniques  
The first recommended technique for the detection of waterborne pathogens is the 
use of molecular detection techniques based off of nucleic acids. With this method 
individuals can screen for the presence of thousands of pathogens present. By identifying 
the harmful pathogens in a community, locals have the ability to design treatment 
facilities to target their elimination. The five types of molecular detection techniques can 
be found below.  
Polymerase chain reaction (PCR) 
PCR is one of the most common techniques to detect for the presence of 
waterborne pathogens [14]. It effectively amplifies a small amount of DNA by 
denaturing, annealing, and polymerization in order to produce millions of copies [16]. 
Although the test typically takes up to four hours to conduct, this method can detect 
pathogens such as E. coli and Salmonella [17]. Within the PCR technique there are two 
different uses: multiplex PCR and real-time PCR. Multiplex PCR relies off of the use of 
numerous primer sets to increase several objects in a reaction. Although being time 
efficient, this method is limited in that only a specified number of organisms can react. 
An alternative method is to use real-time PCR. The real-time feature allows individuals to 
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more closely examine different microbial agents in order to properly determine their 
species [12].  
16S rRNA 
The 16S rRNA approach involves the extraction of nucleic acids from water, 
amplifying them via PCR and 16S rRNA primers, cloning, sequencing, and using a 
genetic library for identification [18]. This test is not only limited to detect the microbial 
agent, but it also specifies the microbial species via the genetic library. The most 
common infectious agent can be found using this technique and can be turned into an 
indicator for future studies. Although this method has shown success with bacteria, it is 
not useful for detecting viruses due to the lack of a common 16S rRNA gene [12].  
Fluorescent in situ hybridization (FISH)  
FISH, also known as fluorescence in situ hybridization, is a technique that relies 
off of identifying the presence or absence of sequences of DNA on chromosomes. This 
method is based on the principle of hybridizing a sample with rRNA oligonucleotide 
probes that are covalently labeled with a fluorescent dye [14]. It essentially involves the 
treatment of microbial cells with a solution, hybridizing them on a glass slide with 
probes, and then using confocal laser microscopy, epifluorescence, or flow cytometry to 
visualize the probes. This method is useful for quantifying microbial populations in a 
sample [12]. FISH can also be used in clinical studies in order to confirm the identity of a 
potential infectious pathogen.  
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Oligonucleotide DNA Microarrays 
A recent promising molecular technique relies off of the use of microarrays. With 
this method individuals can investigate multiple water samples at the same time [19]. 
Although this technology can be used to indicate and specify the microbial agent, it 
involves a large amount of data and processing and introduces a high cost [14]. The 
science behind this method relies off of the targeting of the 16S or functional genes. One 
recent development using this concept is the 12k microarray that uses electrochemical 
detection (ECD) technology. The basis for ECD relies off of a redox active reaction to 
identify positively hybridized probes. This semiconductor technology uses individual 
microelectrodes synthesized with customized oligonucleotides. By coupling these 
microelectrodes with computer software programs, scientists can rapidly test for 
thousands of potential infectious agents in a single water sample [12]. Companies that 
with commercialized DNA microarrays include Corning, Affymetrix, and Agilent 
Technologies [14].  
Drawbacks of Molecular Techniques 
Although molecular techniques provide a precise and accurate means of 
identifying bacteria, they still are limited in the detection of viruses. Molecular methods 
may allow the researcher to identify the potential infectious agents to a community. 
However, these techniques do not provide information relating to the real infectious risk 
for a community's population, as well as introduce a high risk of false positive results due 
to high sensitivity [14]. In his article, Recommended advanced techniques for waterborne 
pathogen detection in developing countries, Fatimah Alhamlan recommends adopting 
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these molecular-based techniques in order for developing countries to improve the quality 
of their water supplies [12]. Although such methods may work for developed countries, 
those with low-resources often lack the sufficient funds and/or training in order to 
perform such techniques.  
Immunology-Based Methods 
Immunology-based techniques rely off of the use of antibody-antigen binding. In 
this binding individual monocolonal/polyclonal antibodies will bind to specific antigens. 
Some examples of immunology-based techniques include enzyme-linked immunosorbent 
assays (ELISA), serum neutralization tests (SNT), and immunofluorescence [14]. The 
SNT method can detect viruses and is based on mixing a sample taken from a plaque 
assay with an antiserum and then investigating the decrease of infectivity by the plaque 
assay [20]. An indirect immunofluorescence technique on the other hand can be used to 
detect protozoan parasites. This method involves using a fluorescent tag with a secondary 
antibody that then binds to the primary antibody [21]. Lastly, ELISA technique is a 
colorimetric way of identifying the concentration of antibodies or antigens in solution 
[22]. Although immunology-based methods are useful to detect multiple pathogens, they 
exhibit low sensitivity and false negative results due to cross-reactivity with similarly 
related antigens [14, 23]. 
Biosensor-Based Methods 
Recently biosensor technology has allowed for an accurate and rapid means of 
detecting waterborne pathogens. In 2001 Rose and Grimes reported water quality 
monitoring techniques being stuck in the past, as they envisioned a more real-time and 
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operational decision making approach [23]. Many individuals believe that a distributed 
network of sensors that continuously monitors a water supply is the solution to the 
problems proposed by current laborious techniques [7]. Electrochemical biosensors are 
able to do accomplish this by using various biorecognition molecules based on their 
binding affinities with infectious agents [24]. This binding creates changes in resistance, 
conductance, or capacitance on the surface [14]. Other biosensors that can be used are 
optical, thermometric, micromechanical, or mass-based sensors. Biosensors have the 
portable advantage along with the ability to take real-time measurements at a relatively 
low cost. Drawbacks to these sensors include a high pH and temperature sensitivity [14]. 
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CHAPTER THREE 
LECTIN SCIENCE AND APPLICATIONS 
 
Lectins, sugar-binding moieties most commonly found in plants, have been 
widely studied for their use in biological assays. Recently researchers have been 
investigating their high affinity to bind to certain bacteria. This chapter serves to give an 
overview of lectin bonding as well as their potential use to detect for waterborne 
pathogens.  
 
3.1 Overview of the Science Behind Lectins and their Bonding 
Lectins are carbohydrate-binding proteins that have been a key study of cell 
biology for decades. Boyd and Shapley first introduced the definition of lectins as a class 
of plant agglutinins, a few of which exhibited specificity for human blood groups [25]. 
"Lectin," as they coined the molecule, stems from the Latin word "legere" meaning "to 
select" or "to choose". The modern definition of the term was modified slightly to define 
a lectin as a non-immunoglobulin glycoprotein that includes a carbohydrate recognition 
domain that does not modify the carbohydrates with which they bind [26]. Known to 
have high affinities for functional groups containing sugars, they are often grouped 
together and agglutinate cells that contain complementary saccharides [27].  
Plant-derived Lectins 
The majority of the history of lectins points to their plant origins. Like animals, 
plants exhibit evolved mechanisms essential for non-self-recognition and anti-microbial 
defense [27, 28]. This defense against pathogens stems from pattern recognition receptors 
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(PRRs) bound to the cell membrane classified as C, G, L, and LysM types. PRRs have 
the ability to identify the pathogen/microbe-associated molecular patterns 
(PAMPs/MAMPs) and the damage-associated molecular patterns (DAMPs). Once a 
pathogen is detected, PRRs trigger an intracellular signaling cascade known as the 
PAMP/MAMP-triggered immunity (PTI/MTI) as seen in Figure 3.1. This reaction will 
lead to multiple transcriptional changes, stomatal closures, and cell wall strengthening 
thus greatly limiting the pathogen's growth [27].  
 
Figure 3.1: Role of Plant-Derived Lectins in the PTI/MTI response and 
Intracellular Signaling Cascade [27].  
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 Along with the PTI/MTI mechanisms, the effector-triggered immunity (ETI) is 
also another essential defense mechanism that plants utilize against pathogens. Unlike 
PTI/MTI, which involve reactions both inside and outside the cell, ETI occurs inside the 
cell. Evolved pathogens frequently produce effectors that dampen or block the PRR 
signaling. To combat this the cell utilizes a class of intracellular plant receptors that 
consists of nucleotide-binding and leucine-rich repeat domain (NB-LRR) in order to 
detect the effectors and create an ETI response. Overall the combination of the PTI/MTI 
and ETI responses leads to apoptosis, or programmed cell death [27].  
Animal-derived Lectins 
Although originally discovered in plants, lectins can also be found in invertebrates 
and vertebrates, including mammals [25].  Similar to the plant response to pathogens, 
animals have PRRs consisting of C-type lectins that mount an immune response. A 
diagram of the role of lectins in the innate immune response can be seen in Figure 3.2. 
One example of a commonly studied C-type lectin with a crucial role in the immune 
response is the mannose-binding protein (MBP), or referred to as the mannose binding 
lectin (MBL) 2. Typically the MBL2 is produced by the liver and secreted into serum. 
However, when the body is subjected to pathogenic agents, inflammatory cells secrete 
cytokines that trigger the liver to produce large amounts of MBL2. MBL2 then serves as 
a PRR and can bind to mannose, N-acetylmannosamine, N-acetylglucosamine, fucose, 
and glucose allowing surface-level interaction between viruses, yeasts, fungi, protozoa, 
and bacteria. Once the C-terminal on MBL2 binds to the carbohydrate groups on the 
surface of the pathogen, the N-terminal can communicate with receptors on macrophages. 
 25 
The signaling between the MBL2 and the macrophages effectively triggers phagocytosis. 
Other than its role in phagocytosis, lectins in the body also play important roles in 
endocytosis during antigen presentation, glycoprotein clearance, and the binding of sperm 
to oocytes [27].   
 
 
 
 
 
Figure 3.2: Role of Animal-Derived Lectins in the Innate Immune Response [27]. 
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3.2 Use of Lectins in Cell Bio Assays 
 Lectins have been heavily studied for their use as biotechnological tools in cell 
biology. Their use in this field can be split into two primary categories: imaging for 
histological purposes involving free floating, fluorescently tagged lectins, and cell 
identification/sorting where surface-bound lectins target and attach to molecules present 
in the environment.  
Lectins in Immunofluorescent Applications 
 One primary use for lectins is in immunofluorescence to use fluorescently tagged 
lectins to stain areas of interest. Lectin immunofluorescence is a quick, sensitive, and 
useful technique to visualize specific cells and/or structures [29]. For example Pena et al. 
tested 7 different lectins for use in human skeleton muscle visualization [30]. The results 
indicated that peanut agglutinin (PNA) provides a clear sarcolemmal staining, while Ulex 
europeus agglutinin I (UEA I) and Soybean agglutinin (SBA) exhibited a clear staining 
of blood vessels [30]. Kostrominova also investigated the use of lectins for the 
visualization of skeletal muscle fiber outlines. She found wheat germ agglutinin (WGA) 
not only produced positive results when compared to the more costly laminin staining 
technique, but also extended the application to connective tissue in bone, tendons, and 
ligaments. Kostrominova concluded that the use of fluorescent WGA lectin staining 
provided a quick, cheap, and reliable method to visualize skeletal muscle fiber and 
general connective tissue [29].  
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Surface-bound Lectins for Cell Identification 
 Lectins serve as excellent cell identifiers, or biomarkers, due to the broad 
functional groups with which they bind. These proteins have the ability to reversibly bind 
carbohydrates of glycoproteins, glycolipids, and polysaccharides. The high affinity bonds 
in which they form allow for lectins to function as mediators of cell recognition [31]. Due 
to their ability to spot glycan molecules, lectins have been used primarily in lectin-
affinity chromatography. In this technique lectins located on gel beads adsorb 
glycoproteins and are washed with a specific carbohydrate. The result is glycoproteins 
that have undergone fractionation and purification, essential for the isolation of the 
protein in small amounts [32].  
 Another application of lectins takes advantage of their natural antitumor effect. 
Some examples include lectin use for treating leukemia, breast cancer, and hepatoma. 
Specifically Flammulina velutipes prevented the proliferation of leukemia L1210 cells as 
seen in Ng et al.  [33]. In addition Lin et al. found that Glycine max extracted from black 
soybean was found to resist hepatoma HepG2 and breast cancer MCF7 cell proliferation 
[34]. These lectins along with many others utilize the apoptosis-induced effect the 
proteins have on various cancer cell lines [32]. 
 A more recent technique outlined in Glycan and Lectin Microarrays for 
Glycomics and Medicinal Applications by Katrlik et al. outlines the use of lectin 
microarrays for cell identification via fluorescence. In this technique lectins are aligned 
on panels placed on a single chip with fluorescently tagged samples hybridized to the 
array [31,32]. This technology enables the glycoprofiling tool to be high-throughput, 
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sensitive, and the ability to rapidly detect for carbohydrates. One big advantage of using 
lectin microarrays is the array's potential to detect for whole cells, a limitation of the 
conventional technique. Lectin arrays show promise to distinguish healthy human serum 
from serum containing an infectious bacterial agent as well as cancerous tissue cell lines 
[31]. 
  
3.3 Lectin Applications in Pathogen-Detecting Biosensors 
 A more recent application of lectins is their use as biorecognition elements in 
electrochemical biosensors. Lectins have the unique ability to reversibly interact with 
mono- and oligosaccharides, compounds spread throughout the surface of bacterial cells 
[35,36]. Individuals can use these proteins and their carbohydrate binding abilities to 
identify microbial presence.  
 One current electrochemical technique outlined by Varshney et. al involves the 
use of interdigitated array microelectrode-based (IDAM) impedance biosensors to detect 
bacterial cells. Varshney and his colleagues chemically attach anti-E. coli antibodies to 
gold, platinum, titanium, and other costly metals [37]. With these microelectrodes he and 
his team have been able to detect the presence of E. coli based off of an increase in 
impedance when the bacteria is introduced to the environment [37].  
 Despite the fact that protein-protein interactions are stronger than protein-
carbohydrate linkages, lectins are smaller, more chemically stable, and tend to better 
retain their activity compared to antibodies [35,38]. In addition, lectins are far less 
expensive than antibodies, and can be used to detect pathogens within 5-10 minutes. Lu 
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et al. describes a magnetoelastic biosensor to detect E. coli. To accomplish this Lu and 
his colleagues utilized a 1µm layer of Bayhydrol 110 to serve as a foundation for 
Concanavalin-A (ConA). When E. coli is placed around the sensor, the O-antigen of the 
bacteria and the mannose modified surface cause shifts in the resonant frequency. These 
shifts can be used to quantify the E. coli concentration with a detection limit of 60 
cells/mL [39].  
 Although Lu's research highlights the importance of a sensitive, quick, one-step, 
quantitative, and specific method for bacterial detection, the magnetosensor is only 
capable of detecting Gram-negative bacteria [39]. In order to expand pathogen detection 
and impart specificity, the use of multiple lectins must be taken into consideration. Plant-
based lectins such as Concanavalin-A (ConA) from jackfruit, Triticum vulgaris (Wheat 
Germ Agglutinin, WGA), and Arachis hypogaea (Peanut Agglutinin, PNA) are only a 
few examples that have been found to exhibit a high specificity for foreign bacteria, 
fungi, and other microorganisms [27, 31, 40]. For example, E. coli and S. aureus bind to 
both ConA and WGA, while S. aureus binds strongly to PNA but not E. coli [31,40]. 
These lectins are not just limited to E. coli and S. aureus, however, but ConA and PNA 
are able to bind to many infectious bacteria, parasites, and protozoa such as Salmonella 
typhimurium [41], Schistoma manosoni [42], Leishmania donovani [43], and malaria 
parasites to some degree [44].  
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CHAPTER FOUR 
DESIGN EVOLUTION 
 
 Prior to August 2015 the research group utilized proof of concept methods in 
order to test the ability for the technology to detect for the presence of pathogens. In 
order to increase reproducibility of results and to shrink the technology to a more feasible 
commercial scale, the group designed and tested 3D printed sensors. This chapter outlines 
the technology's design evolution  
 
4.1 Probe Design 
 There has been a consistent trend of scaling down the probes, from the 200 mL 
beakers used at the project’s conception, to the 2.0 mL vials used over the past year, to 
the 0.4 mL wells used currently. Past developments of probe designs can be seen in 
Figure 4.1, shown below.  
   
Figure 4.1: Previous Probe Designs Prior to August 2015. 
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 The previous probe designs in Figure 4.1 allowed the research group to record 
data, however they posed some limitations. Perhaps the largest limitation was the 
inability to set a permanent fixed distance between the two copper wires. By not having a 
fixed distance the wires moved around and could touch, causing the calculated resistance 
to go to approximately 0Ω, creating a short. Creating this fixed distance became crucial 
for precision purposes as well, as to allow repeatability in the results and decrease noise 
from the movement of the electrodes. The protocols for the previous beaker and 
Eppendorf vial setups can be found in Appendices B and C respectively. 
 
 
 In order to correct for the fixed distance issue, the group decided to create a 3D 
printed sensor (Figure 4.2) with wires placed horizontally in order to allow for an easy-
access well at the top. The total volume was decreased from 1.5 mL with the previous 
Eppendorf vial setup to 200 µL. The results from the sensor became repeatable, however 
the resistance increased by a magnitude of 10 and it took longer to detect the presence of 
Figure 4.2: First 3D Printed Sensor with Horizontal Electrode Insertion.   Date: 
9/28/15 
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the bacteria. The group believes that the increase in magnitude was due to the superglue 
that used in order to prevent the solution from leaking out of the sensor. After further 
research it was confirmed that superglue does act as an insulator, thereby impeding 
electricity.  Once discovering that the superglue was the impedance source, the members 
initially looked into grommets and/or O-rings in order to block the fluid flow without 
interfering with the electrical current. However, after looking into price quotes for these 
additions we decided it would be better to change the design back to having the probes 
vertically positioned. The group also hypothesized that a vertical design would cause less 
lectins to fall off the electrodes compared to the horizontal approach. 
 After discarding the horizontal approach, the group reverted back to a vertical one 
similar to the original setup but with a fixed distance between the electrodes as seen in 
Figure 4.3. This setup produced better results, but it was difficult to inject the bacteria 
and hard to manufacture due difficulties with the printer's resolution when printing the 
tight hole diameter.  
Figure 4.3: First Iteration of 3D Printed Vertically Aligned Sensor. The top and 
bottom pieces snap together. Date: 10/25/15  
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 The sensor design shown in Figure 4.4 is composed of a 3D printed probe that 
contains supports to hold the electrodes and a well for the actual testing to occur. The 
well's volume totals 400 µL. The group tested this setup and it produced similar results 
when compared to past larger volume editions. In addition, the fixed distance took away 
the high probability of the electrodes shorting out.  
The group noted that the resistance values seen using the new probes are higher 
than the values seen with previous probe design. The researchers attest this difference to 
the reduction in the amount of lectin-coated surface area used in the current version as 
well as a smaller total solution volume. Additionally, the group aims test the effects of 
wire spacing on the reactivity to the introduction of bacteria, which can be done by 
altering the template before printing the probes. The default wire spacing that the group 
used for experimentation was 1 mm. 
 
 
 
Figure 4.4: 3D Printed Sensor with Easy-Access Well. Date: 11/16/15 
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 The 3D sensor in Figure 4.5 above is the current sensor used for testing. It 
contains the same fixed distances as Figure 4.4 but with a wider base to prevent the 
sensor from tipping over during testing. The previous sensor model also had issues when 
trying to transfer the electrodes from the lectin solution to the PBS solution for testing. 
When this transfer occurred, the research group noted that the legs would break off, 
which caused the top of the sensor to not properly attach to the well. The current design 
also has the benefit of being reusable. After testing the research group can sterilize the 
wells with a 70% ethanol solution for use during later experiments. The protocols for the 
sensors in Figure 4.4 and 4.5 can be found in Appendix D. 
 
 
 
 
 
Figure 4.4: Current Reusable 3D Printed Sensor. This sensor has a volume of 400 µL 
and an easy-access Well. Date: 2/25/16 
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4.2 Circuit Design 
The initial circuit design consisted of a Wheatstone bridge design found in Figure 
4.6. The bridge was considered an unbalanced bridge due to the unknown resistance 
supplied by the sensor, RX. To approximate the value of RX the group read in voltages at 
nodes A and B and came up with the derivation in Figure 4.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Unbalanced Wheatstone Bridge Circuit. This was used to calculate the 
unknown resistance (RX). The research group currently uses R1 = 2 kΩ. For the sake of 
testing R1 can be adjusted to the baseline of the sensor resistance to provide more 
accurate results.  
R1 
R1 
R1 
RX 
A B Vin = 1.5 V 
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Experiments prior to November 2015 were completed on a breadboard connected 
to a TI DAQ. This system would often suffer from loose wires either within the 
breadboard or between the board and the DAQ. The loose wires would result in 
inconsistent data that would often require upwards of fifteen minutes to diagnose which 
Figure 4.8: Breadboard Circuit prior to November 2015  
Figure 4.7 Derivation to Approximate the Value of RX in Figure 4.6. 
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wire was causing the error. The previous layout of the circuit can be found in Figure 4.8. 
The DAQ can be seen at the bottom of the image. 
  
 
 
 
 
  
 The breadboard system was eventually replaced with the printed circuit board 
(PCB) shown in Figure 4.9. The circuit possesses the same functionality as the 
breadboard but eliminates the potential for loose wires. To fabricate the board the 
research group first designed the circuit in Eagle and printed it on a single sided copper 
plate before etching the excess copper away and soldering in the circuit components.  
 
 
Figure 4.9: New Circuit PCB as of November 2015 designed in silico with Eagle 
software.  
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4.3 Data Acquisition via LabVIEW 
 In order to supply the 1.5 V input voltage seen in Figure 4.6 a NI-USB-6008 
DAQ Assistant was used. This DAQ Assistant is also responsible for acquiring the data 
for further processing in LabVIEW. Once the data reaches the DAQ it is passes through 
an analog to digital converter and is processed using the block diagram in Figure 4.10. 
The signal is acquired at 10 samples per second and first passes through a sample 
compression node to calculate the average of the 10 samples to output to the formula. The 
formula is configured such that it takes in voltage values from nodes A and B found in 
the circuit in Figure 4.6, and outputs the unknown resistance between the sensor's 
electrodes, RX. The formula node consisted of the same calculation performed in Figure 
4.7. Once calculated, the value of RX is then graphed using a waveform chart for the user 
to view on the front panel in Figure 4.11. The front panel also enables the user to toggle 
the input voltage. Note: For the experiments listed in this paper an input voltage of 1.5 V 
was used in order to not excite any bacteria off of the electrodes. On the front panel the 
user can also alter the save file that the block diagram writes to during data acquisition. In 
the excel file time elapsed, resistance, and the voltage difference between nodes A and B 
are recorded for each sensor tested.  
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Figure 4.10: LabVIEW Block Diagram consisting of data acquisition set to a 
sampling rate of 10 samples/s, mean sample compression to 1 sample, formula 
for sensor resistance, live voltage, resistance, and waveforms, and the 
recording of the acquired data to excel.  
Figure 4.11: LabVIEW Front Panel allowing the user to toggle between input 
voltage and the save location that the program writes to. The respective live 
resistances, voltages, and waveforms are shown for each of the experiments.  
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CHAPTER FIVE 
IMPEDIMETRIC PATHOGEN-SENSING BIOSENSORS FOR USE IN LOW-
RESOURCE SETTINGS 
 Lectins are known to demonstrate binding activity to various waterborne 
pathogens, including a variety of bacteria. In order to determine their effectiveness for 
bacterial detection it is essential to assess their ability to identify Gram-positive and 
Gram-negative bacteria, as well as their detection limits. This chapter serves to 
investigate the ability of lectins to bind to S. aureus and E. coli as well as expand on the 
benefits of the technology for water testing and clinical environments. 
 
5.1 Background 
 The World Health Organization (WHO) estimates that waterborne diseases alone 
account for over 3.4 million deaths per year [45]. With such a high mortality, the need to 
provide a fast and accurate means of identifying the source of microbial contamination in 
communities as well as quickly diagnosing microbial infection in patients is fundamental 
to the quality of care and paramount to public health. In resource-poor settings a shortage 
of clinics pose a major problem, as patients are required to travel long distances, many of 
which cannot afford the return trip to retrieve their test results. Between visits most 
clinics are limited to microscopic analyses, telehistology, or media-based metabolic tests, 
which can take as long as a week. In addition, less-monitored water supplies in these 
areas become breeding grounds for bacteria that can affect an entire community. 
Although diagnostics have made improvements in recent years, there is still a need for 
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quick and more affordable tests in the clinic as well as water testing environments to 
identify infectious pathogenic agents.  
Waterborne Pathogens 
Waterborne pathogens can be split up into three different classes: bacteria, 
viruses, and parasites. These pathogens are often introduced into water supplies when 
infected individuals deposit fecal matter that contains harmful microbes. In many cases 
this can occur when sewage lacking proper treatment is re-deposited into the water 
system. However, runoff of feces may diffuse into groundwater and in turn be used as a 
source of water. Although the movement of pathogens creates lower concentrated 
dilutions, they still pose a risk to society's well being [46].  
For the purpose of this paper the research group focused in on the testing of 
bacteria, a large group of prokaryotic microorganisms. The size of bacteria can range 
between a few microns, however they can vary significantly between species. Bacteria 
may be found in the shapes of spheres, but also as spirals and rods as well as temperature 
ranges from subzero to boiling [46].  
 Bacteria can be split into two different categories: Gram-positive and Gram-
negative. In order to differentiate between the two, scientists perform a Gram-staining 
test. This test involves a staining technique that detects the peptidoglycans of the cell in 
order to gather insight on the bacterium's physical and chemical properties. Once stained, 
Gram-positive bacteria appear purple under a microscope, while Gram-negative bacteria 
remain a pink color. Gram-positive bacteria have a thick, smooth peptidoglycan layer that 
retains most of the stain. Examples of Gram-positive bacteria include Staphylococcus 
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aureus (S. aureus), Streptococcus pneumoniae, and Bacillus anthracis among others. 
Gram-negative bacteria, on the contrary, exhibit thin and wavy outer membranes. Some 
examples of Gram-negative bacteria include Escherichia coli (E. coli), the cause of the 
majority of urinary tract infections, as well as Pseudomonas aeruginosa, and Klebsiella 
pneumoniae. The latter two are responsible for healthcare-related drug-resistant 
infections that can enter the body through catheters, wounds, or ventilators and cause 
infections [46]. 
Lectins 
Lectins are carbohydrate-binding proteins that have been a key study of cell 
biology for decades. Boyd and Shapley first introduced the definition of lectins as a class 
of plant agglutinins, a few of which exhibited specificity for human blood groups [47]. 
"Lectin," as they coined the molecule, stems from the Latin word "legere" meaning "to 
select" or "to choose". The modern definition of the term was modified slightly to define 
a lectin as a non-immunoglobulin glycoprotein that includes a carbohydrate recognition 
domain that does not modify the carbohydrates with which they bind [48]. Known to 
have high affinities for functional groups containing sugars, they are often grouped 
together and agglutinate cells that contain complementary saccharides [49]. A more 
recent application of lectins is their use as biorecognition elements in electrochemical 
biosensors. Lectins have the unique ability to reversibly interact with mono- and 
oligosaccharides, compounds spread throughout the surface of bacterial cells [50,51]. 
Individuals can use these proteins and their carbohydrate binding abilities to identify 
microbial presence. 
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Plant-derived Lectins 
The majority of the history of lectins points to their plant origins. Like animals, 
plants exhibit evolved mechanisms essential for non-self-recognition and anti-microbial 
defense [49, 52]. This defense against pathogens stems from pattern recognition receptors 
(PRRs) bound to the cell membrane classified as C, G, L, and LysM types. PRRs have 
the ability to identify the pathogen/microbe-associated molecular patterns 
(PAMPs/MAMPs) and the damage-associated molecular patterns (DAMPs). Once a 
pathogen is detected, PRRs trigger an intracellular signaling cascade known as the 
PAMP/MAMP-triggered immunity (PTI/MTI). This reaction will lead to multiple 
transcriptional changes, stomatal closures, and cell wall strengthening thus greatly 
limiting the pathogen's growth [49].  
 Along with the PTI/MTI mechanisms, the effector-triggered immunity (ETI) is 
also another essential defense mechanism that plants utilize against pathogens. Unlike 
PTI/MTI, which involve reactions both inside and outside the cell, ETI occurs inside the 
cell. Evolved pathogens frequently produce effectors that dampen or block the PRR 
signaling. To combat this the cell utilizes a class of intracellular plant receptors that 
consists of nucleotide-binding and leucine-rich repeat domain (NB-LRR) in order to 
detect the effectors and create an ETI response. Overall the combination of the PTI/MTI 
and ETI responses leads to apoptosis, or programmed cell death [49].  
Current Pathogen-Sensing Biosensor Design in Literature 
 One current electrochemical technique outlined by Varshney et al. involves the 
use of interdigitated array microelectrode-based (IDAM) impedance biosensors to detect 
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bacterial cells. Varshney and his colleagues chemically attach anti-E. coli antibodies to 
gold, platinum, titanium, and other costly metals [53]. With these microelectrodes he and 
his team have been able to detect the presence of E. coli based off of an increase in 
impedance when the bacteria is introduced to the environment [53]. Despite the fact that 
protein-protein interactions are stronger than protein-carbohydrate linkages, lectins are 
smaller, more chemically stable, and tend to better retain their activity compared to 
antibodies [50,54]. In addition, lectins are far less expensive than antibodies, and can be 
used to detect pathogens within 5-10 minutes. 
  Lu et al. describes a magnetoelastic biosensor to detect E. coli. To accomplish 
this Lu and his colleagues utilized a 1µm layer of Bayhydrol 110 to serve as a foundation 
for Concanavalin-A (ConA). When E. coli is placed around the sensor, the O-antigen of 
the bacteria and the mannose modified surface cause shifts in the resonant frequency. 
These shifts can be used to quantify the E. coli concentration with a detection limit of 60 
cells/mL [55]. Although Lu's research highlights the importance of a sensitive, quick, 
one-step, quantitative, and specific method for bacterial detection, the magnetosensor is 
only capable of detecting Gram-negative bacteria and is not designed for low-resource 
settings [55].  
Development of an Impedimetric Pathogen-Sensing Biosensor 
 The research group has developed a novel way to test for waterborne pathogens 
using copper electrodes coated with lectins, or sugar-binding plant proteins. During 
testing the group found that following the introduction of bacteria, the pathogen binds 
strongly to the lectin-coated electrodes. This binding impedes the flow of electricity 
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passing between the two electrodes, thereby increasing the resistance. A schematic 
showing the working principle of the technology can be seen in Figure 5.1. Bacteria, as 
natural insulators, bind to lectins, which can exhibit a higher affinity for specific 
pathogens. For example, in the figure below E. coli. demonstrated exceptional binding to 
ConA, while roughly maintaining equilibrium resistance for BSA. By quantifying the 
change in resistance and comparing the change to how bacteria interacts with wires 
coated in a non-reactive blood protein, a diagnosis can be achieved as to the presence of a 
significant amount of bacteria. This project is currently being approached as a testing 
device for bacteria in humans or in water sources. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Schematic Showing the Working Principle of the Lectin-based 
Sensors. Example data is also included showing the electrode's response in the 
presence of E. coli. Bacteria bind to the ConA-coated electrode (dark green) but 
only show minimal binding to the control bovine serum albumin (BSA) electrode 
(light green). The orange arrows indicate the addition of bacteria followed by an 
increase in the measured resistance between the ConA electrodes within a few 
minutes.  
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5.2 Materials and Methods 
 During the testing of bacteria the research group utilized three different setups for 
the testing of the bacteria. The basis for these setups consisted of a large beaker, 
Eppendorf vial, and 3D printed sensor designs. The materials and methods for each of 
these setups are listed below. 
Large Beaker Setup 
 The initial prototyping of the design took place in a 250 mL beaker filled with 
175 mL PBS solution (Figure 5.2). The PBS solution was selected because of its 
common use as a buffer solution in biological research and has a similar ion 
concentration to solutions in the body. Concanavalin A (ConA), the lectin used for this 
setup was prepared by using sterile technique to dissolve 50 mg of lyophilized ConA 
powder in 40 mL of sterile PBS. Sterile PBS was chosen instead of nonsterile PBS in 
order to prevent ConA from binding with a potential bacterial presence. Once the ConA 
was placed in sterile PBS it was vortexed until the ConA went into solution. The bovine 
serum albumin (BSA) solution was prepared by dissolving a 0.5 mg sample of BSA in 50 
mL of sterile PBS in order to obtain a 1% BSA solution.  
 With the solutions prepared, the next step consisted of coating the electrodes with 
ConA and BSA. Four electrodes, each with dimensions 10 cm by 30 cm were cut, 
cleaned with DI water, scrubbed with a 70% ethanol solution, and left to dry for 10 
minutes. Following the 10-minute period the electrodes were placed in petri dishes and 2 
mL of ConA solution was pipetted on the bottom 1 cm length of 2 electrodes. Likewise 2 
mL of 1% BSA solution was pippeted on the bottom 1 cm length of 2 electrodes. These 
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two sets of electrodes were then set aside to dry for 1 hour. After the 1-hour wait period 
the ConA electrodes showed no liquid residue while the BSA electrodes displayed 
leftover solution. A kimwipe was used to slightly dab off the solution and left to dry for 5 
additional minutes. Each electrode set was then separated by a 0.5 cm distance and taped 
using the outer edge where copper was not present.   
 Once prepared, the electrode sets were placed on opposite ends of the beaker with 
175 mL of PBS and a 1 cm electrode depth in solution. The circuit in Figure 5.3 was then 
connected to each end of the electrode and 1.5 V was inputted from a LabVIEW DAQ. 
The LabVIEW software effectively calculated the resistance between the electrodes in 
each of the electrode sets and reported it to a live waveform graph. The time duration for 
the experiments in this paper varied, but E. Coli with concentration 1.102E4 particles/mL 
was injected in 10 mL increments.  
 
 
 
 
 
 
 
Figure 5.2: Beaker setup Used for Preliminary Testing. The design consists of a 250 mL 
beaker with 175 mL of PBS solution. Two sets of two electrodes each have dimensions 10 
cm by 30 cm and were placed 1 cm into the solution. 
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Eppendorf Vial Setup 
 The Eppendorf vial setup (Figure 5.4) consisted of the same procedure used as 
the aforementioned beaker, but with different volumes of solution and electrodes. In 
order to test the technology's potential on a smaller scale, 14 AWG copper wires were 
used and prepared in the same manner as the larger sheet electrodes. The Eppendorf vials 
were each filled with 1.25 mL PBS and the electrodes were separated such that they were 
not touching. Bacterial concentrations were similar to those used in the beaker setup and 
additions of 250 µL were added during each trial.  
Figure 5.3: Unbalanced Wheatstone Bridge Circuit. This was used to calculate the 
unknown resistance (RX). The research group currently uses R1 = 2 kΩ. For the sake of 
testing R1 can be adjusted to the baseline of the sensor resistance to provide more 
accurate results.  
 
R1 
R1 
R1 
RX 
A B Vin = 1.5 V 
Figure 5.4: Eppendorf Vial Sensor Setup with 14 AWG wire coated electrodes.  
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3D Printed Sensor 
 The 3D printed sensor (Figure 5.5) consisted of a 400 µL well with a top that 
separated the electrodes by 1 mm. Electrode preparation was conducted using the same 
technique as previous setups. Bacterial additions consisted of 40 µL bacteria with E. coli 
concentration 4.46E6 cfu/mL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: 3D Printed 400 µL Sensor shown with holes for the 14 AWG wire coated 
electrodes (top) and an opening for bacterial additions (bottom)  
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5.3 Results 
Clinically Relevant Detection Limits 
 In order to assess the capability of the research group's technology in the clinic, it 
is fundamental to be able to test at clinically relevant concentrations. Figure 5.6 
demonstrates the signal response of the technology at clinically relevant concentrations of 
E. coli. These results were collected by placing the ConA-coated and BSA-coated 
electrodes in PBS and allowed to equilibriate for 15 minutes prior to bacterial additions. 
After equilibrium was reached 10 mL of 11,020 cells/mL bacterial solution was added to 
the beaker with the electrodes. After 25 additional minutes, 5 mL of bacterial solution 
was added. A final 5 mL of bacterial solution was added after a total of 65 minutes had 
elapsed. Resistance measurements were taken for a total of 99 minutes.  
 
Figure 5.6: Signal response (ConA/BSA) to increasing concentrations of E. coli with 
dotted vertical lines representing clinically relevant concentrations for the labeled 
conditions. 
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Effect of Volume on Resistance 
 The research group noted that the effect of bacterial additions resulted in a 
decrease in resistance before binding occurred between the pathogen and the lectin. To 
examine this further the group selected DI water instead of bacteria to exhibit minimal 
binding. Three additions were performed during this experiment at 16, 31, and 44 
minutes with 250 µL of DI water. The results can be seen in Figure 5.7. During testing 
the group noticed that the resistance would sharply decrease before coming back to 
equilibrium. 
 
 
Figure 5.7: Effect of Volume on Resistance. Diagram showing the additions of 250 
µL of DI water results in a decrease in overall resistance. The Eppendorf vial setup 
was used for this experiment. 
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Gram-Positive and Gram-Negative Test Results 
 To assess the technology's ability to detect for Gram-positive and Gram-negative 
bacteria the research group selected S. aureus and E. coli respectively due to their 
common presence and frequency to cause infections. Figure 5.8 demonstrates the 
technology's capability of detecting Gram-positive bacteria using S. aureus as an example 
with BSA as a control. During this experiment 250 µL increments of bacteria was 
introduced at 22, 30, and 38 minutes. Before subsequent additions were added the 
research group waited until the solution had reached equilibrium to obtain a more 
accurate assessment on the binding between the ConA and S. aureus. After each addition 
there is an average of a 1kΩ increase in impedance, showing a strong positive correlation 
when compared to the control. Testing for this experiment was conducted using the 
Eppendorf vial setup.  
Figure 5.8: Results from Gram-Positive Testing with the research group's pathogen-
sensing technology. Additions of 250 µL S. aureus were added 3 times during the 
duration of the experiment. The Eppendorf vial setup was used for this experiment. 
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 Similar to the Gram-positive results, the research group also conducted a Gram-
negative E. coli test. Aside from the substitution of E. coli for S. aureus the protocols 
during both Gram tests are identical. The results from displaying the technology's 
capability of detecting Gram-negative bacteria can be seen in Figure 5.9. Like the S. 
aureus, 3 subsequent additions were added for this experiment at 18, 32, and 46 minutes 
with 250 µL of E. coli at a concentration of 1.102E4 particles/mL.  
 
 
 
 
Figure 5.9: Results from Gram-Negative Testing with the research group's pathogen-
sensing technology. Additions of 250 µL E. coli were added 3 times during the 
duration of the experiment. The Eppendorf vial setup was used for this experiment. 
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Decreasing the Sensor Size to 400 µL 
 The step down in total volume from the beaker to the Eppendorf vial setups still 
produced reliable results for detecting bacterial presence. In order to take this a step 
further the research group 3D printed 400 µL wells for testing.  These sensors were tested 
with 250 µL of PBS and a 50 µL addition of E. coli. The results from this experiment can 
be seen in Figure 5.10. Like the tests with larger volume, the E. coli test with the 400 µL 
sensor exhibited a sharp increase in resistance over a 2.5 minute interval before returning 
to equilibrium.  The BSA in this experiment appeared to undergo a more noticeable 
gradual increase over time. The research group attributes the steady increase in resistance 
is due to electrophoresis and pH changes.  
 
Figure 5.10: 3D Printed 400 µL Bacteria Test with a 40 µL E. coli addition. 
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Comparing 400 µL setup to the 1.5 mL Eppendorf Vial Setup 
 Due to space, smaller volume sensors would be preferred in a clinical setting. The 
research group decided to shrink the experimental volume further by a factor of 5 to a 
total volume of 300 µL out of the 400 µL well. The Eppendorf vial and 400 µL sensor 
setups consisted of 250 µL and 40 µL additions of E. coli respectively. The results for 
this test can be seen in Figure 5.11. The control 1.5 mL sensor exhibited noise, an error 
noticed for the Eppendorf vial setup due to there not always being a fixed distance 
between the electrodes.  
 
 
 
Figure 5.11: Sensor Size Comparison showing the prior Eppendorf vial 1.5 mL design 
compared with a 400 µL volume sensor. Both of the electrodes were coated in ConA 
and 250 µL, 50 µL additions of E. coli were added respectively to the 1.5mL and 
400µL designs. 
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Extended Time Experiment with 400 µL Sensor 
 Although experiments in water testing and clinical setting environments will 
occur within a few minutes, the research group decided to investigate the effect of time 
on the smaller 400 µL sensors. The results from this experiment can be seen in Figure 
5.12. Although electrophoresis and pH changes occur during the experiment, BSA still 
maintains a steady equilibrium when compared to the reacting ConA.  
 
 
 
 
Figure 5.12: Extended Time Bacteria Test with the 3D Printed 400 µL Sensor. 
Additions of 40 µL E. coli were added two times during the trial. The 3D printed 400 
µL was used for this experiment. 
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5.4 Discussion 
 The overall basis of the pathogen-sensing technology has proven to be promising 
for future developments in water treatment and clinical environments. For water testing 
lower specificity requirements are needed as it is just necessary to identify the presence 
of a waterborne pathogen and what steps to take (i.e. add chlorine). Sample volume is 
also not as important for water testing since a larger sample of water can be gathered for 
testing if need be. For clinical diagnostics, however, this is a different case. A device for 
the clinical environment needs to be able to detect for pathogens using small volumes of 
blood. It is also necessary in the clinic to be able to address which specific pathogen is 
present in the blood sample. Identifying the microbial strain and type can help the 
hospital staff determine the treatment options such as what antibiotic to prescribe the 
patient. The results in this paper confirm the detection of E. coli and S. aureus and the 
technology's ability to perform at clinically relevant concentrations. 
 The assembled technology proved to be capable of effectively identifying Gram-
negative and Gram-positive bacteria at clinically relevant concentrations. Figure 5.6 
illustrates the feasibility of the pathogen-sensing technology to detect for E. coli at 
concentrations associated with catheter-based urinary tract infections (UTI) and acute 
cystitis [56,57].  
 Preliminary testing of Gram-positive S. aureus and Gram-negative E. coli showed 
a large increase in resistance (>1kΩ) for bacterial additions in the presence of ConA. The 
reason behind why the lectin ConA was selected for these experiments is three-fold. Most 
importantly, ConA has the ability to bind with various waterborne pathogens including S. 
 62 
aureus and E. coli [58]. Second, ConA is widely available in many of the developing 
countries around the globe such as Kenya, Uganda, India, and Brazil among others 
[57,59]. Third, ConA is very affordable for testing purposes. The lectin can be purchased 
in large quantities from many biological companies for less than $100. Like ConA bovine 
serum albumin (BSA) is also very affordable and a commonly available reagent in 
laboratories. BSA was selected to control for any nonspecific binding that may occur in 
the test solution. Exhibiting minimal binding in the presence of bacteria, BSA represents 
an excellent control. 
 Although the Gram-positive and Gram-negative experiments in Figure 5.8 and 
Figure 5.9 respectively both tested positive for the detection of the pathogens there are 
some notable key differences between the two tests. Figure 5.8 shows that following the 
addition of S. aureus, the resistance increased at a steady rate after all three additions. 
Figure 5.9, on the other hand, illustrates a quick increase before reaching equilibrium as 
well as a slight corresponding decrease in resistance following equilibrium and prior to 
the next addition. This decrease was also found in other experiments such as the one in 
Figure 5.11. The group attributes this slight decrease in resistance to either bacteria-
bound lectins falling off of the electrode and/or surrounding bacteria pulling off the 
lectins. Perhaps more interesting about the Gram-testing results is the promising response 
by S. aureus. The large increase in resistance due to the presence of the bacteria shows 
the potential for this technology to detect other Gram-positive bacteria, including highly 
debated methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a clinically 
relevant pathogen due to its resistance to a variety of antibiotics currently on the market. 
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Although a strand of S. aureus, MRSA displays a thicker cell wall that protects it form 
antiseptics such as acriflavine [60]. Due to similar binding mechanisms, the research 
group hypothesizes that the pathogen-sensing technology discussed would be able to 
detect for MRSA. Due to a greater cell wall thickness, the binding of MRSA to ConA 
would hypothetically lead to a greater change in resistance when compared to S. aureus. 
Scientific literature confirms that lectins harness the capability to type for MRSA. A. 
Muñoz et al. reported that 21 (65.6%) of the 32 commercially available lectins tested 
agglutinated in the presence of MRSA. In the experiment, the group found that ConA 
alone agglutinated in 36 (59%) of the 61 MRSA isolates [61].  
 Throughout the experiments mentioned in this paper a difference in the starting 
and finishing resistance values was noted. The research group hypothesizes larger 
volumes of solution to lead to a smaller starting and finishing resistance value. This 
occurs when comparing the results from the 3D printed 400 µL well to the Eppendorf vial 
setup in Figure 5.11. Although both of the setups experienced a 4kΩ change in the 
testing period, the control started off at a 2kΩ resistance while the 3D printed sensors 
started off at an 8kΩ resistance. This difference can also be observed in Figure 5.7, 
where additions of DI water show an overall decrease in resistance. This rapid decrease is 
similar to what occurs when bacterial additions are performed before they arrive back to 
equilibrium.  
 Although the pathogen-lectin agglutination accounts for the majority of the 
change in impedance following bacterial additions, steady changes in resistance are also 
due to electrophoresis and pH changes. Perhaps most evident in the change in resistance 
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of the BSA electrodes in Figure 5.10, electrophoresis and pH changes are believed to 
have caused the gradual increase after the addition of bacteria. When a current is applied 
an induced electric field is created. Electrophoresis occurs due to negatively charged 
DNA moving as anions toward the cathode [62]. The addition of current also adds 
electrons into the solution that can render hydrogen ions chargeless. The lack of the 
charge of these ions would lead to a drop in hydrogen ion concentration, and thus an 
increase in pH since pH=-log([H+]). The user can indirectly control the current affecting 
the pH of the system. For the results in this paper an input voltage of 1.5 V was used. 
This voltage was selected in order to not induce too much current to the system as well as 
to limit frying the bacteria off of the electrodes, thereby decreasing the overall resistance.  
 
5.5 Conclusion 
 The electrode designs mentioned in this paper were found to be successful at 
detecting Gram-positive and Gram-negative bacteria at clinically relevant concentrations. 
Due to the capability of lectins to bind with a vast array of waterborne pathogens this 
technology can be expanded to water treatment settings as well as the clinic. For water 
treatment this technology is in greater need in the developing world to detect for the 
presence of a pathogen in a water supply. Once the pathogen is identified, users can take 
the appropriate steps in order to ensure safe drinking water. This applied science can also 
be used in the clinic with a higher specificity in order to determine which waterborne 
pathogen the patient ingested. Having this technology in the clinic will allow physicians 
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to prescribe the appropriate antibiotics to ensure that we are bettering the lives of patients 
worldwide.  
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CHAPTER SIX 
OVERALL CONCLUSIONS AND FUTURE WORK 
 This chapter serves to summarize findings and report future work that needs to be 
done in order to commercialize the technology for a water testing and clinical 
environment.  
 
6.1 Overall Summary of Findings 
 Overall the research group has demonstrated the ability to detect the presence of 
E. coli and S. aureus at clinically relevant concentrations. The group has also developed a 
scaled down 3D printed sensor that effectively senses the presence of pathogens at a 
volume that would be more suitable for the clinical environment. The advantage of this 
lectin technique compared to the traditional cell culture is that it is more time efficient. 
Results have shown that the presence of the waterborne pathogen can be detected within 
20 minutes, drastically different than the cell culture technique that can last up to a week 
before the hospital staff can follow up with the patient and prescribe the appropriate 
antibiotics.   
 
6.2 Challenges with Bacteria Samples 
 Towards the end of testing the group aimed to test the technology in blood as well 
as other lectin and bacteria combinations. However, after performing repeat testing of E. 
coli and ConA/BSA tests the group found difficulty in obtaining impedance responses 
that matched the previously observed experiments. The group attests this to the use of a 
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new sample of bacteria that was not healthy thus not eliciting an appropriate response. 
The timeline of experiments between the use of the working E. coli and the unhealthy E. 
coli can be seen in Appendix E. Initial experiments with the working E. coli (Figures 
E.1-E.2) show successful pathogen detection. Upon the acquisition of the new unhealthy 
E. coli results did not show a difference between ConA and BSA (Figures E.3-E.6). 
Testing of the previously working E. coli in Figures E.7-E.8 confirmed that the newly 
acquired E. coli was not healthy. Although the previously working E. coli responded 
appropriately when added to the sensors in Figures E.7-E.8, the increase in resistance 
was not as high as previous trials. These findings highlight the need to take care of the 
bacteria samples rather than solely storing the samples at 2°C and not changing out the 
media. The group has recently acquired a microbiologist who will see that the bacteria 
samples are properly taken care of prior to testing.  
 
6.3 Future Work 
  Before this research moves forward it is necessary to divide the technology into 
two research groups: water treatment and clinical diagnostics. For the water treatment 
group, a device needs to be created such that it can detect bacterial presence in water and 
be able to identify the presence of a pathogen so that the operator may know what steps 
to take. This device has lower specificity requirements and sample volume is not as 
important. For the majority of waterborne pathogens chlorine can be used in order to 
clean the water supply. The second research group will focus on the clinical diagnostics 
side, which has higher specificity requirements. For the clinical device it is necessary to 
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be able to detect pathogens in blood at low sample volumes. After detecting the 
waterborne pathogen that the patient ingested, the doctor can then prescribe antibiotics 
accordingly. A proposed protocol for the testing of the technology's ability to detect for 
pathogens in blood can be found in Appendix F.  
 In addition to the two research group focuses it is essential to expand the lectin-
pathogen database in order to detect for the greatest number of waterborne pathogens 
possible. A proposed protocol as well as different lectin/bacteria combinations mentioned 
in literature can be found in Appendix G [63]. The difficulty with lectins that will have 
to be addressed when analyzing the signals is that lectins are not specific to certain 
pathogens. In other words, lectins such as ConA have a wide variety of microbial agents 
that they can bind to. For this reason it is essential to analyze the characteristics on a 
case-by-case basis to determine which pathogens bind with which lectins and at which 
degree/rate. A variety of lectins with known impedance responses will allow the group to 
fingerprint a pathogen sample that will give the technology the ability to type unknown 
pathogenic samples.  
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Appendix A 
Common Waterborne Pathogens 
Table A.1: World Health Organization List of Common Waterborne Pathogens [14] 
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Appendix B 
Materials and Methods for the Beaker Proof of Concept Experiment 
 
Large Beaker Sensor Setup 
Materials 
1.) 250 mL beaker  
2.) 175 mL non-sterile PBS solution 
3.) 4 mL ConA in sterile PBS solution (1.25 mg lyophilized ConA powder per 1 mL 
sterile PBS) 
4.) 4 mL BSA in sterile PBS solution (0.01 mg of BSA per 1 mL sterile PBS) 
5.) Spray bottle of 70% Ethanol solution 
6.) 10 mL DI Water 
7.) Four single side plated copper boards cut 10 cm by 30 cm 
8.) LabVIEW data acquisition software and NI-USB-6008 DAQ Assistant 
9.) 2 Wheatstone bridge circuits with R1 = 2kΩ and input voltage set to 1.5 V 
10.) 30 mL E. coli with concentration 1.102E4 particles/mL 
Methods 
1.) Clean the copper boards with DI water and 70% ethanol solution and allow them to 
dry for 10 minutes. 
2.) Pipette 2 mL of ConA solution onto the bottom 1 cm of two copper plates and 2 mL 
of BSA solution onto the bottom 1 cm of  the remaining to copper plates. Wait for 1 hour.  
3.) Place 175 mL non-sterile PBS solution in the 250 mL beaker. 
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4.) Space the ConA copper plates 1 cm apart. Also space the BSA plates 1 cm apart and 
ensure there are at least 2 inches between the ConA and BSA sets. Use tape on backside 
of the copper boards to secure spacing as necessary. 
5.) Submerge the copper plates 1 cm deep in the non-sterile PBS solution while 
maintaining the spacing mentioned in step 4.  
6.) Connect nodes A and B of the first Wheatstone bridge circuit to the two different 
ConA-coated plates. 
7.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
BSA-coated plates. 
8.) Connect the NI-USB-6008 DAQ Assistant to a computer with LabVIEW and run the 
program.  
9.) Wait until the resistance reaches equilibrium before adding 10 mL of E. coli additions. 
10.) Wait for equilibrium after increase in the ConA sensor's resistance and repeat 10 mL 
E. coli additions as necessary. 
 
 
 
 
 
 
 
 
 78 
Appendix C 
Materials and Methods for the Eppendorf Vial Sensor Setup 
 
1.5 mL Eppendorf Vial Setup 
Materials 
1.) 4 2 mL Eppendorf  vials 
2.) 2.5 mL non-sterile PBS solution 
3.) 1.5 mL ConA in sterile PBS solution (1.25 mg lyophilized ConA powder per 1 mL 
sterile PBS) 
4.) 1.5 mL BSA in sterile PBS solution (0.01 mg of BSA per 1 mL sterile PBS) 
5.) Spray bottle of 70% Ethanol solution 
6.) 10 mL DI Water 
7.) Four 14 AWG copper wires 8 cm in length 
8.) LabVIEW data acquisition software and NI-USB-6008 DAQ Assistant 
9.) 2 Wheatstone bridge circuits with R1 = 2kΩ and input voltage set to 1.5 V 
10.) 0.5 mL E. coli with concentration 1.102E4 particles/mL 
Methods 
1.) Clean the copper wires with DI water and 70% ethanol solution and allow them to dry 
for 10 minutes. 
2.) Pipette 1.5 mL of ConA solution into 1 Eppendorf vial and 1.5 mL of BSA solution 
into another Eppendorf vial. Place two copper wires in the ConA solution and 2 copper 
wires in the BSA solution. Wait for 45 minutes.  
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3.) Pipette 1.25 mL non-sterile PBS solution in 1 Eppendorf vial. Repeat this for the last 
remaining Eppendorf vial. 
4.) Space the ConA-coated copper wires 2 mm apart. Repeat this for the BSA-coated 
copper wires. To secure the separation, use cardboard and tape as necessary. 
5.) Submerge the copper wires in the non-sterile PBS solution up to the 1.5 mL mark on 
the Eppendorf vials. 
6.) Connect nodes A and B of the first Wheatstone bridge circuit to the two different 
ConA-coated wires. 
7.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
BSA-coated wires. 
8.) Connect the NI-USB-6008 DAQ Assistant to a computer with LabVIEW and run the 
program.  
9.) Wait until the resistance reaches an equilibrium before adding 250 µL of E. coli 
additions. 
10.) Wait for equilibrium after increase in the ConA sensor's resistance and repeat 250 µL 
E. coli additions as necessary. 
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Appendix D 
Materials and Methods for the Current 3D printed 400 µL Sensor Setup 
 
3D Printed 400 µL Sensor Setup 
Materials 
1.) 2 3D printed tops with 1 mm spacing between electrode holes and 4 400µL well 
bottoms 
2.) 400 µL non-sterile PBS solution 
3.) 1.5 mL ConA in sterile PBS solution (1.25 mg lyophilized ConA powder per 1 mL 
sterile PBS) 
4.) 1.5 mL BSA in sterile PBS solution (0.01 mg of BSA per 1 mL sterile PBS) 
5.) Spray bottle of 70% Ethanol solution 
6.) 10 mL DI Water 
7.) Four 14 AWG copper wires 3 cm in length 
8.) LabVIEW data acquisition software and NI-USB-6008 DAQ Assistant 
9.) 2 Wheatstone bridge circuits with R1 = 2kΩ and input voltage set to 1.5 V 
10.) 80 µL E. coli with concentration 1.102E4 particles/mL 
Methods 
1.) Clean the copper wires with DI water and 70% ethanol solution and allow them to dry 
for 10 minutes. 
2.) Insert two wires in the electrode holes on the 3D printed tops for the ConA sensor. 
Pipette 200 µL of ConA solution into 1 400 µL well. Repeat this for the BSA sensor. 
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Place the tops of both ConA and BSA sensors into their appropriate lectin and BSA 
solutions. Wait 45 minutes. 
3.) Pipette 200 µL non-sterile PBS solution into each of the remaining two 3D printed 
400 µL wells. 
4.) Place the tops with the coated wires inserted into the wells with the 200 µL non-sterile 
PBS. 
5.) Connect nodes A and B of the first Wheatstone bridge circuit to the two different 
ConA-coated wires. 
6.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
BSA-coated wires. 
7.) Connect the NI-USB-6008 DAQ Assistant to a computer with LabVIEW and run the 
program.  
8.) Wait until the resistance reaches an equilibrium before adding 40 µL of E. coli 
additions. 
9.) Wait for equilibrium after increase in the ConA sensor's resistance and repeat 40 µL 
E. coli additions as necessary. 
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Appendix E 
Challenges with the Impedance Responses of E. coli Samples 
Figure E.1: 3D printed 400 µL Sensor Response Prior to Testing Unhealthy Bacteria 
Trial 1. An addition of 40 µL working E. coli was added during this experiment. 
 
3D printed 400 µL Sensor Response Prior to Testing Unhealthy Bacteria Trial 2. An 
addition of 40 µL working E. coli was added during this experiment. 
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Figure E.4: Eppendorf Vial Sensor Response to Unhealthy Bacteria Trial 1. A 250 µL 
addition of unhealthy E. coli was used during this experiment.  
Figure E.3: 3D Printed 400 µL Sensor Response to Unhealthy Bacteria. A 40 µL 
addition of unhealthy E. coli was used during this experiment. 
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Figure E.5: Eppendorf Vial Sensor Response to Unhealthy Bacteria Trial 2. A 250 µL 
addition of unhealthy E. coli was used during this experiment.  
 
 
Figure E.6: Ratio (ConA/BSA) of Figure E.5 Sensor Response Data. The ratio 
approaches a limit of 1 showing no difference between ConA and the control. These 
results show limited to no binding between the ConA and the E. coli.  
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Figure E.8: 3D Printed 1.5 mL Sensor Response to Healthy Bacteria Trial 2. The 
healthy bacteria used is the same as the previous working E. coli. A 250 µL addition 
of healthy E. coli was used for this experiment. 
Figure E.7: 3D Printed 1.5 mL Sensor Response to Healthy Bacteria Trial 1. The 
healthy bacteria used is the same as the previous working E. coli. A 250 µL addition 
of healthy E. coli was used for this experiment. 
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Appendix F 
Proposed Testing Methods for Blood Trials 
Materials  
1.) 4 mL of human blood serum 
2.) 2 3D printed tops with 1 mm spacing between electrode holes and 4 400µL well 
bottoms 
3.) 400 µL non-sterile PBS solution 
4.) 1.5 mL ConA in sterile PBS solution (1.25 mg lyophilized ConA powder per 1 mL 
sterile PBS) 
5.) 1.5 mL BSA in sterile PBS solution (0.01 mg of BSA per 1 mL sterile PBS) 
6.) Spray bottle of 70% Ethanol solution 
7.) 10 mL DI Water 
8.) Four 14 AWG copper wires 3 cm in length 
9.) LabVIEW data acquisition software and NI-USB-6008 DAQ Assistant 
10.) 2 Wheatstone bridge circuits with R1 = 2kΩ and input voltage set to 1.5 V 
11.)  1.6 mL of E. coli at a concentration of 1.0E4 molecules/mL  
Methods 
1.) Clean the copper wires with DI water and 70% ethanol solution and allow them to dry 
for 10 minutes. 
2.) Insert two wires in the electrode holes on the 3D printed tops for the ConA sensor. 
Pipette 200 µL of ConA solution into 1 400 µL well. Repeat this for the BSA sensor. 
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Place the tops of both ConA and BSA sensors into their appropriate lectin and BSA 
solutions. Wait 45 minutes. 
3.) Pipette 200 µL non-sterile PBS solution into each of the remaining two 3D printed 
400 µL wells. 
4.) Place the tops with the coated wires inserted into the wells with the 200 µL non-sterile 
PBS. 
5.) Connect nodes A and B of the first Wheatstone bridge circuit to the two different 
ConA-coated wires. 
6.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
BSA-coated wires. 
7.) Thaw blood packet in media bath if necessary. 
8.) Mix 1 mL blood serum with 1000 µL E.coli and vortex 
     Mix 1 mL blood serum with 500 µL E. coli and vortex 
     Mix 1 mL blood serum with 100 µL E. coli and vortex 
9.) Connect the NI-USB-6008 DAQ Assistant to a computer with LabVIEW and run the 
program.  
8.) Wait until the resistance reaches an equilibrium before adding 40 µL blood serum. 
9.) End the experiment and repeat the experiment for all infected blood mixtures 
mentioned in Step 8.  
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Appendix G 
Lectin and Bacteria Combinations and Proposed Multiple Lectin Protocol 
 
Lectin Pathogen 
  E. coli S. aureus M. phlei 
Concanavalin A 3(+) 3(+) 3(0) 
Arachis hypogaea 3(0) 3(+) 3(++) 
Ulex europaeus 2(++) 1(+) 3(0) 1(+) 2(0) 
Triticum vulgaris 3(++) 3(++) 3(0) 
Helix pomatia 3(++) 3(+) 3(++) 
Tetragonolobus purpureas 3(+) 3(0) 3(0) 
Dolichos biflorus 3(+) 3(0) 3(0) 
Lens culinaris 3(++) 3(++) 3(+) 
Lycopersicon esculentum 3(++) 3(+) 3(+) 
 
 
 
 
 
Table G.1: Short List of Commercially Available Lectins and Their Binding Response to 
Bacteria. Three trials were ran for each lectin/pathogen combination. Resistances greater than 
200 Ω (++), 0 to 200 Ω (+), and no increase in resistance (0) are listed accordingly [63]. 
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Materials and Methods for Multiple Lectin Test 
Foundation for Experiment: PNA binds to S. aureus but not E. coli; ConA binds to both 
S. aureus and E. coli 
Materials 
1.) 3 3D printed tops with 1 mm spacing between electrode holes and 6 400µL well 
bottoms 
2.) 600 µL non-sterile PBS solution 
3.) 200 µL ConA in sterile PBS solution (1.25 mg lyophilized ConA powder per 1 mL 
sterile PBS) 
4.) 200 µL PNA in sterile PBS solution (1.25 mg lyophilized PNA powder per 1 mL 
sterile PBS) 
5.) 200 µL BSA in sterile PBS solution (0.01 mg of BSA per 1 mL sterile PBS) 
6.) Spray bottle of 70% Ethanol solution 
7.) 10 mL DI Water 
8.) 6 14 AWG copper wires 3 cm in length 
9.) LabVIEW data acquisition software and NI-USB-6008 DAQ Assistant 
10.) 3 Wheatstone bridge circuits with R1 = 2kΩ and input voltage set to 1.5 V 
11.) 80 µL E. coli with concentration 1.102E4 particles/mL 
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Methods 
1.) Clean the copper wires with DI water and 70% ethanol solution and allow them to dry 
for 10 minutes. 
2.) Insert two wires in the electrode holes on the 3D printed tops for the ConA sensor. 
Pipette 200 µL of ConA solution into 1 400 µL well. Repeat this for the PNA and BSA 
sensors. Place the tops of both ConA, PNA, and BSA sensors into their appropriate lectin 
and BSA solutions. Wait 45 minutes. 
3.) Pipette 200 µL non-sterile PBS solution into each of the remaining three 3D printed 
400 µL wells. 
4.) Place the tops with the coated wires inserted into the wells with the 200 µL non-sterile 
PBS. 
5.) Connect nodes A and B of the first Wheatstone bridge circuit to the two different 
ConA-coated wires. 
6.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
PNA-coated wires. 
7.) Connect nodes A and B of the second Wheatstone bridge circuit to the two different 
BSA-coated wires. 
8.) Connect the NI-USB-6008 DAQ Assistant to a computer with LabVIEW and run the 
program.  
9.) Wait until the resistance reaches an equilibrium before adding 40 µL of E. coli 
additions. 
10.) Wait for equilibrium and end the program. 
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11.) Repeat these materials and methods for 40 µL of S. aureus and 40 µL of a 1:1 E. coli 
to S. aureus solution. 
 
 
 
